186 related articles for article (PubMed ID: 25936887)
41. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
Wang F; Lou JF; Cao Y; Shi XH; Wang P; Xu J; Xie EF; Xu T; Sun RH; Rao JY; Huang PW; Pan SY; Wang H
Exp Mol Med; 2015 May; 47(5):e162. PubMed ID: 25952770
[TBL] [Abstract][Full Text] [Related]
42. Clinical implication of microrna for lung cancer.
Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
[TBL] [Abstract][Full Text] [Related]
43. [MicroRNA-26a and Tumor].
Song Q; Xu K
Zhongguo Fei Ai Za Zhi; 2017 Nov; 20(11):769-774. PubMed ID: 29167007
[TBL] [Abstract][Full Text] [Related]
44. MicroRNAs and anticancer drugs.
Xing Z; Li D; Yang L; Xi Y; Su X
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):233-9. PubMed ID: 24492536
[TBL] [Abstract][Full Text] [Related]
45. [MicroRNA in Various Aspects of Cancer Development].
Nambara S; Mimori K
Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
[TBL] [Abstract][Full Text] [Related]
46. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
[TBL] [Abstract][Full Text] [Related]
47. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
[TBL] [Abstract][Full Text] [Related]
48. The role of microRNA in resistance to breast cancer therapy.
Robertson NM; Yigit MV
Wiley Interdiscip Rev RNA; 2014; 5(6):823-33. PubMed ID: 25044299
[TBL] [Abstract][Full Text] [Related]
49. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
50. Bioinformatics analyses combined microarray identify the desregulated microRNAs in lung cancer.
Guo WG; Zhang Y; Ge D; Zhang YX; Lu CL; Wang Q; Fan H
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1509-16. PubMed ID: 23771539
[TBL] [Abstract][Full Text] [Related]
51. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
[TBL] [Abstract][Full Text] [Related]
52. Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression.
Yamamoto K; Ito S; Hanafusa H; Shimizu K; Ouchida M
PLoS One; 2015; 10(9):e0137887. PubMed ID: 26367773
[TBL] [Abstract][Full Text] [Related]
53. MicroRNAs in melanoma development and resistance to target therapy.
Fattore L; Costantini S; Malpicci D; Ruggiero CF; Ascierto PA; Croce CM; Mancini R; Ciliberto G
Oncotarget; 2017 Mar; 8(13):22262-22278. PubMed ID: 28118616
[TBL] [Abstract][Full Text] [Related]
54. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
[TBL] [Abstract][Full Text] [Related]
55. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
56. [The role of miRNAs in the pathogenesis of pituitary adenomas].
Németh K; Darvasi O; Szücs N; Czirják S; Butz H
Orv Hetil; 2018 Feb; 159(7):252-259. PubMed ID: 29429349
[TBL] [Abstract][Full Text] [Related]
57. Regulation of expression of microRNAs by DNA methylation in lung cancer.
Singh DK; Bose S; Kumar S
Biomarkers; 2016 Nov; 21(7):589-99. PubMed ID: 27122255
[TBL] [Abstract][Full Text] [Related]
58. MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Wang Q; Wang S; Wang H; Li P; Ma Z
Exp Biol Med (Maywood); 2012 Mar; 237(3):227-35. PubMed ID: 22345301
[TBL] [Abstract][Full Text] [Related]
59. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
60. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer.
El-Bayoumy K; Das A; Narayanan B; Narayanan N; Fiala ES; Desai D; Rao CV; Amin S; Sinha R
Carcinogenesis; 2006 Jul; 27(7):1369-76. PubMed ID: 16399772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
